Avient Corp (AVNT) 2021 Q1 法說會逐字稿

Good day, thank you for standing by. Welcome to the Q1 2021 Avient Corporation Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Joe Di Salvo, Vice President, Treasurer and Investor Relations. Please go ahead.

Thank you, Jorel, and good morning, and welcome to our first quarter 2021 earnings call. Before beginning, we would like to remind you that statements made during this webcast may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements will give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectation and involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Please refer to the investor presentation for this webcast posted on Avient's website for a number of factors that could cause actual results to differ.

During the discussion today, the company will use both GAAP and non-GAAP financial measures. Please refer to the presentation posted on the Avient website where the company describes non-GAAP measures and provides a reconciliation for historical non-GAAP financial measures to their most directly comparable GAAP financial measures.

In addition, unless otherwise stated, comparisons to prior year will be pro forma for the Clariant Masterbatch acquisition as if the business had been together during all periods referenced.

Joining me today is our Chairman, President and Chief Executive Officer, Bob Patterson; and Senior Vice President and Chief Financial Officer, Jamie Beggs.

Now I will turn the call over to Bob for some opening comments.

Well, thank you, Joe, and good morning, everyone. We have record results to share today as well as increased optimism for the rest of the year as demand conditions are stronger than previously expected. While the world still has a long way to go with respect to combating COVID-19, we are optimistic that as an increasing percentage of the world's population receives the vaccination, this too will help drive demand.

We start today and begin by reviewing our results for Q1, where we achieved the highest level of organic sales growth in the last 10 years. Certainly, we're benefiting from a pandemic recovery, but our results are also a result of many things and a lot of hard work. Our performance is underpinned by the investments we have made to transform our portfolio to one that is more specialized, focused on sustainable solutions and concentrated on high-growth end markets.

And our team delivered these results despite supply chain disruptions that have impacted most everyone in the industry. We thank our suppliers and our own supply chain leaders for exemplary work to make this possible. I'm also pleased we were able to expand operating margins by 200 basis points during a period of inflation, by being on top of pricing, capturing synergies ahead of schedule and an improving mix of product sales. And this has all translated to adjusted operating income growth of 43% and adjusted EPS growth of 68%.

All 3 of our business segments contributed to our success, each delivering record revenue and operating income for the quarter. Our Color business grew operating income 39% due to robust demand for consumer applications as well as sustainable solutions. We are also benefiting from early synergy capture related to the Clariant Masterbatch acquisition. Specialty Engineered Materials expanded operating income 55%, driven by continued strength in sales of our composite technologies as well as new business gains in health care and consumer applications.

And last but certainly not least, our Distribution segment delivered record operating income of $24 million, an increase of 26% over the prior year. This was led by strong demand and new business closes in health care and consumer. Truly outstanding performance by all of our segments to begin the year.

It's an understatement to say that we have been investing in sustainable solutions and new technologies such as composites that serve high-growth end markets. Over the years, our portfolio has undergone a tremendous and deliberate transformation, with an increased focus on specialty applications. Not only has this been an important contributor to our recent growth, but the benefits of improved mix are clearly driving higher margins despite raw material inflation.

For investors who followed us in our early years, you know margin expansion was a hallmark of our success. Now as Avient, it is and will be again. When we announced the acquisition of Clariant Masterbatch, there were some questions regarding our ability to improve the margins to the level of the legacy PolyOne Color business.

I'm pleased to report that in the first 9 months of ownership, we have made significant progress in this regard, while also seeing an uptick in legacy PolyOne margins. For the legacy Clariant business, we have expanded EBITDA margins from 11.9% to 17.4%. I have to say there is so much energy and excitement that is being generated from the combined organizations even in this primarily virtual environment.

I've seen a number of integration efforts over the years and couldn't be more proud of how we have come together culturally and operationally for each other and our customers. As our teams continue to work together, we have been able to accelerate our synergy capture and realized $11 million in the first quarter. And in addition, we expect the full year realization to be $45 million, up from our previous estimate of $35 million a few months ago.

During our February webcast, we provided a bridge on the key drivers behind our 2021 growth projections, which included sustainable solutions, health care, composites and growth outside the U.S. and emerging regions. We've updated this bridge for Q1 performance. And you can see how these drivers contributed to our first quarter results.

And these are the same areas that you will continue to hear us refer to when discussing our ability to grow in excess of the market over the long term. From an end market perspective, our largest segments, which are tied to long-term growth platforms, performed exceptionally well during the quarter. In particular, health care and consumer applications led the way with 22% and 24% growth, respectively.

You may look at packaging and question its relative performance, but don't. This simply reflects how well packaging did in the early days of the pandemic last year and specifically in Asia, which was impacted most in Q1 in 2020. The health of our focused end markets are a big reason we are delivering record levels of revenue and operating income.

Combined with the optimism from the ongoing vaccine rollout, it gives us growing confidence in the economy and our ability to deliver. So as you read in our news release this morning, we have increased our outlook for the year, which Jamie will now cover as part of her remarks. Jamie?

Thank you, Bob. We are pleased to provide an update on our second quarter and full year projections for 2021 as things have improved since our last outlook we provided back in February. Just as we finished the first quarter with strong results, we are seeing robust demand for our formulations continue into the second quarter.

So for Q2, we expect total company sales of $1.1 billion, which is an increase of approximately 26% over the prior year. As we saw in Q1, we expect the health care and consumer end markets to drive a large portion of this growth. This is truly impressive when you consider that total company health care sales increased by 12% in the second quarter of last year, and now we will see double-digit growth in the second quarter of this year.

Recall that last year, our health care sales benefited from COVID response applications such as face masks. Well, this year, we expect health care sales to grow -- growth to be driven by new business gains in applications such as glucose monitoring devices, antigen test kits and drug delivery applications.

We also see recovering demand for applications used in elective procedures such as labware and medical equipment. Consumer sales will benefit from continued underlying demand for specialty technologies used in outdoor high-performance applications. This would include things like off-road vehicles and sporting equipment. All in, we expect adjusted EPS for the quarter to be approximately $0.80 per share, which is a 90% growth over the prior year.

For the full year, we now expect total company sales to increase 14% to $4.3 billion. Current demand patterns would suggest a continued recovery into the third quarter as our customers are still trying to keep up with their orders and replenish low levels of inventory. We expect seasonally lower sales in the fourth quarter, consistent with our views we mentioned in our last earnings call.

The 14% sales growth, combined with $45 million of synergy capture that Bob previously mentioned, is expected to result in an adjusted EPS of $2.80 per share, which is 45% growth over the prior year. The increased sales and earnings will also benefit our free cash flow generation, which we now anticipate to be $275 million, up from the $250 million we previously estimated.

This includes the investments in working capital to support our sales growth as well as restructuring activities to capture synergies associated with the Clariant Masterbatch integration. From a leverage perspective, we expect to finish the year at 1.9x net debt to adjusted EBITDA. This is an organic projection, assuming cash remains on the balance sheet.

Our preference, though, will be to put that cash to work, pursuing strategic M&A with a focus on specialty engineered material opportunities and particularly on composite technologies. Composites are just one technology in our growing portfolio of sustainable solutions. We have a sustainability strategy that's broad, and we're very proud to be leading. We'll be continuing to share sustainability updates and information with our investors throughout the year. And I'll now turn the call back over to Bob for more on that and some concluding comments.

Thank you, Jamie. Sustainable solutions are at the forefront of Avient. It's our future, and it's how we will differentiate ourselves. But sustainability at Avient is about more than just our material solutions. We are committed to and investing in each of our 4 Ps, people, product, planet and performance. These investments are already paying off as you have seen.

Our commitment to people in building our culture has resulted in employee engagement scores that now have us among the top workplaces in the world. For the second consecutive year, we achieved a perfect score on the Corporate Equality Index of the Human Rights Campaign. And we were recently recognized by Newsweek as one of America's most responsible companies. These improvements not only help us as an employer of choice, but they also are important as the world moves toward becoming more sustainably conscious, with the responsibility of corporations playing a crucial role in the communities where we operate.

Disclosing our activities in environmental, social and governance areas has also been a focus for our teams. Our sustainability report is a comprehensive document that highlights our efforts in these areas. We continue to make improvements in telling our story, which recently was recognized by Sustainalytics who ranked us top quartile in our industry this month. For us, sustainability isn't just about taking care of the planet. It's a growth driver, as revenue for our sustainable solutions portfolio has grown from $275 million in 2016 to $560 million last year.

As we look to the future, you can expect that we will continue to focus on our customers' needs in this regard. We do this in areas like improving recyclability, lightweighting, providing eco-conscious solutions and solutions for sustainable infrastructure. In our most recent sustainability report, we included goals that we are working to achieve by 2030.

And these are goals that will benefit the planet and the people of the world while at the same time adding value to Avient's stakeholders.

Before we take some questions, we have included a few other slides related to peer comparisons that I think are helpful to better think about Avient and our value. As companies report earnings this year and compare to 2020, there will be many stories of significant growth being delivered. But think about this as a differentiator.

I'd like you to recall that for the full year last year, our EBITDA did not decline versus 2019, it grew. And our EBITDA projections for 2021 are 27% higher than 2019. And that's because of the end markets we serve and how we serve them. We are an asset-light, high-touch business, and we generate lots of cash.

Our expertise is in formulation, increasingly in sustainable solutions where we expect double-digit sales growth for the foreseeable future. As our financial performance and projections have improved, I expect our valuation will do the same.

We are certainly not out of the woods with respect to COVID as the recent increase in cases in India reminds us. We keep this top of mind at all times everywhere around the world. And first and foremost, we have to take care of our associates, our customers and each other's health and safety and supply challenges abound. That is well known.

But am I optimistic? You bet. More so than I've ever been in my 13 years here. I knew we were embarking on something special when I joined the company in 2008 at the early stages of then PolyOne's transformation. And I know it now, as Avient and as a specialty company with an inspired and energized team.

With that, I'll open it up for questions.

(Operator Instructions) Our first question comes from Bob Koort with Goldman Sachs.

Bob, I wanted to ask you, maybe tying into that last enthusiastic outlook you've got. Slide deck is helpful, you feel that you guys aren't very capital-intensive. So why delever below 2 turns, why not just start buying back your stock before the market recognizes what you see?

Yes. I mean, look, we have a number of acquisitions that we are looking at, and I do see some momentum in that regard. Obviously, I think last year, things stalled out a bit. And just in terms of our ability to move some discussions forward. So I'm optimistic that we can gain some traction, and that really would be our preferred use of cash, is to put that to work, as Jamie mentioned today really in the Engineered Materials segment and hopefully something in composites.

Got you. And then on Clariant, I think at the time of the deal, the margins there were maybe 500 bps lower than what you've got in the legacy PolyOne Color business or Avient Color business. That's closed that gap now to 360, something like that. Can you fully close it? What's the time frame on doing that, if you can? Or if you can't quite close it, what's the hindrance?

Yes. I mean, I think we can close it. I think that with the continued capture of synergies, particularly as we get to the next phase of that next year, that will go a long way towards doing that. As you know, there are some mix differences between the 2 businesses, they structurally have some differences. But I think they're going to be very close when it's all said and done.

First and foremost, we have to capture these synergies. And second, the combined organizations are doing an outstanding job of managing inflation right now and getting price, improving mix. And I think that's going to go a long way towards doing just that.

Our next question comes from Mike Sison with Wells Fargo.

Really nice start to the year and outlook. Bob, in terms of revenue from sustainable solutions, I guess, it was $560 million in 2020, likely approaching $600 million plus in '21. In terms of growing that business, do you need to -- or can you expand capacity to accelerate that? And I know one of your goals in one of the slides said 100% of the products, the packaging will be recyclable or usable. Can you maybe just walk us through how much capacity you have in that type of area and then what you can do to grow it?

Yes. I mean, look, we have -- for the most part, capacity, and if I just focus on the Color business, it's primarily driven by personnel. We really do have more than adequate capacity to grow. And obviously, by bringing the legacy Clariant and legacy PolyOne organizations together, that's only improved. So I don't look at fixed assets or machines as a hindrance in any way.

For us, it really is about investing in innovation and tackling some of these changes. And that's why you'll see in our 2030 goals that the preponderance of innovation is going towards sustainable solutions right now. I kind of view that as the primary area of focus and investment for us to drive that growth.

Right. Great. And then in terms of your organic growth outlook for '21, pretty impressive. It's sort of a step change to understand you have easy comps in 2Q. What do you think beyond '21 the sustainable growth rate -- organic growth rate for Avient is going forward?

Yes. I mean, look, I think for now, it's really good to continue to reference these growth drivers that we've had in our materials over the last 6 to 9 months, focused on sustainable solutions, composites, and health care, all of that lending itself to a 6.5% growth rate. Obviously, we're seeing better than that right now. But I think that's still the right way to think about that. And I'm pretty sure our assumption therein was a GDP number of sort of 2% to 3%, if you will. So better than GDP, those being the primary drivers.

Our next question comes from Frank Mitsch with Fermium Research.

Yes. Thanks for posting the slides concurrently with the release. Much appreciated. I wanted to follow up on the Distribution business. You posted a record year in the first quarter, but yet you did suffer some logistic issues during the quarter as well. I was curious if you could size that and how much of a tailwind might that be for the second quarter in the Distribution business?

Yes. I can't put an exact number on that, but I can say that I do think the Distribution business could have had a better first quarter had it not been for some of these supply chain challenges. Those continue right now. And so I'm not sure this necessarily moves immediately just take what we didn't get done in Q1 and add it to Q2 because at this point, those supply challenges persist and may through the second quarter.

So at the moment, I wouldn't classify that as a tailwind. I think the team would look at it as we still got some work to do to catch up to match demand, right? I mean, look, it's a good thing that we have these orders out there, and there is so much demand. It's a very challenging time right now to meet that. So I guess that's the best way I would characterize that, Frank.

Got you. I was almost going to ask Jamie since you didn't have an exact number, maybe she did, but I'll pass for now. And then if I think about your guide for the second quarter, it's below the first quarter. And historically, PolyOne would see a modest increase in the second quarter versus the first quarter. Are you being conservative here?

Well, number one is that I think that with the increased presence that we now have in Europe as a result of the Clariant Masterbatch acquisition, that does actually tilt seasonality more towards the first quarter than it has in the past. Combine that with the sale of PP&S 18 months ago, which always had its strongest quarter in Q2. So I think we need to see this play out a bit in how seasonality really factors into our quarters. But like as I said, we've got very strong orders and demand out there with some of the supply chain challenges we have to overcome that to deliver. And we'll see how the quarter plays out.

Our next question comes from Vincent Andrews with Morgan Stanley.

This is Angel on for Vincent. Just if I could expand on that last question about conservatism, I guess, as we look at 3Q and 4Q, obviously, there's some seasonality in the fourth quarter, but it seems like the back half is, based on your guidance, meaningfully below kind of where we're at in the first half. So could you just provide a bridge as to how we go from kind of that $0.80 in 2Q to kind of 3Q levels that you're kind of implying in the guidance?

Yes. Look, I think there certainly is a seasonality element to that and also probably very consistent to what we said back in February in our first call for the year, which is that I think we're being conservative with respect to the second half of the year. So I mean, when you just look at the sales growth projections implied for the second half vis-a-vis the first half, I think that certainly say that's the case. So I think we'll have a better read on what the second half looks like as this quarter progresses. And hopefully, we are being conservative and can do better than what we've projected so far.

And if I could, I guess, just expand on that a little bit. You had a very helpful slide on raw materials. I guess how are you thinking about that? Is part of that conservatism based on, I guess, what we're seeing in terms of inflation? And do you feel that you'll be able to kind of offset that with pricing? Or how are you viewing kind of the overall dynamic?

Yes. I mean I think the team has done a great job of doing that so far to start the year and feel confident about that for the second quarter. Whether or not some of these supply chain disruptions and other things that may be driving some of this inflation persist into the second half of the year remains. But our team is really planning for it like, "Hey, look, we've got to go out, capture pricing where we need to." Same thing with respect to freight and freight surcharges.

And we've added that to our businesses where we need to as well. So I feel like we're on it. I think we got it covered. I really couldn't say for certain how long that lasts for the balance of the year.

Your next question comes from P.J. Juvekar with Citi.

Eric Petrie on for P.J. I've been watching some of the sustainable solutions portfolio offerings that you're doing like Rejoin, ColorMatrix, reSound. Could you just talk about how sales growth are in those buckets and peak sales and then kind of give us a sense of what the larger drivers are in your sustainable solutions sales.

Yes. So I mean, you may have seen in Plastics News, I think that came out this week, where we were just highlighting some of the recent technologies that were out there. So in those particular areas, those are all new technologies and just getting started. When we look at the areas for sales growth this year, if I were to broadly categorize them, they are in the areas of barrier, which includes food and beverage containment and enabling the use of less materials.

Secondly would be around lightweighting for a broad range of applications, perhaps most focused on transportation, is probably being the 2 key leaders. Right now, there's a lot of attention given to sort of what I'd describe as eco-conscious materials or bio-based materials. That's still pretty small. I think the growth rate opportunity is there, but that's -- when I just look at delivering revenue this year, that's still a pretty small component of what we expect.

Okay. Helpful. And then secondly, your emerging sales growth was pretty strong with 20% plus income margins. Could you discuss what regions delivered that growth in the end markets?

Yes. So I mean, look, for the most part, that's coming out of Asia. And by far and away, had the highest sales growth in the company. Think about that last year, it was about 13% of total company sales. This year, it's about 17%. So Asia has grown quite a bit. Latin America was up only about 4%. To some extent, we actually think that's COVID-related and having some supply chain disruptions as well. But when I really think about where that growth is coming from, it's certainly by far and away, strongest in Asia.

Our next question comes from Colin Rusch with Oppenheimer.

As you guys are looking at your pipeline of acquisition targets, can you speak to how much of that is really within your existing segments? Or how much is going to move into some of the adjacent areas that are next to your businesses?

Yes. I mean everything that we're looking at right now, I'd say -- look, my sort of philosophy on that is you don't want to get too far away from your core competence with respect to considering acquisitions. So I think everything is very close to what we do. Maybe 1 or 2 can be described as an adjacency, but not too many -- not more than probably one turn away from what we do today. But look, there's a number of things we're looking at, primarily in Engineered Materials.

Great. And then as you think about growth and having kind of a foundation that's stable to support that growth, could you talk about organizational capacity that you need to add and manufacturing capacity and how you evaluate adding manufacturing capacity?

Yes. I mean look, from a capacity standpoint, it's kind of consistent with the comment I made earlier around sustainable solutions. We have plenty of capacity with respect to footprint and machines. The real dynamic that's challenging for us right now, and I think a lot of companies are experiencing this, is just getting enough people, right? And some of this is COVID-related, some of this is demand related as other industries have grown as well. So for us, the primary gating factor really is human resource related and getting enough associates into our facilities to meet that demand.

Our next question comes from Ben Kallo with Baird.

Congrats on the results.

Thank you.

So what I heard you say is that the second half you're being very conservative because the numbers don't make sense to me.

You said, they don't make sense to you?

No, no. Just I mean, like the seasonality, you have a very strong quarter in Q4. You did last year as well. But we have to have a big tick down in the second half to kind of get within your guidance.

I'm not exactly sure if all the words you replayed right there, sorry, I had a hard time hearing you. But yes, I mean, I do think we're being conservative in the second half. And I really do hope that as more of the world gets vaccinated and we do get control of COVID, that there continues to be really good demand through this. There was a -- I mean, another way of thinking about this, there was a good report that I read yesterday on one of our customers in the outdoor industry. And just how little inventory there is right now and how long it's going to take to catch up. And I think we're being conservative in that regard as well. So if that's true and these consumer industries continue to do well, we could do better in the second half than what we have projected right now.

And then just 2 questions. So EM, it looked like that your margins are good there and maybe that has been something that -- what you just alluded to about your outdoor equipment. But maybe also, could you talk about the composites and what you're seeing there from that side?

And then my last question is just on lightweighting. Because it's a big deal for people asking us about the auto industry and electric vehicles and everything. And how much lightweighting growth that you guys are seeing for different applications out there, like might be a year from now or 18 months or 2 years. Has that picked up at all?

Yes. I mean, from a -- composites really has been the key -- one of the key growth drivers in the Engineered Materials segment. I think when I -- if I were to bifurcate composites versus the rest of our solutions, that's probably half the growth that you see in the quarter. As you recall from the past, because of how much investment we have made in composites, the growth there is driving, I think, a disproportionate amount of the margin expansion, which is a good thing.

Lightweighting is certainly an element of that. Actually, I think the lightweighting has even more opportunity when the transportation industry can really pick up. Everyone's aware of supply chain challenges impacting it as well. And I think when that recovers, we can do even better from a composites perspective. So look, I think there's a good level of demand primarily in consumer applications right now.

But longer term, we view this as a double-digit grower for us, just again, based on replacing heavier, less structurally, let's say, design friendly materials with these composites. So we like it a lot, as you know. I think it's got really good growth projections.

Our next question comes from Laurence Alexander with Jefferies.

Two questions. One, can you talk a little bit about how your firm handles labor inflation rather than commodity inflation? I think you've done a good job passing through the feedstock inflation.

And secondly, on the sustainability side, should we be thinking about this as a fairly steady CAGR over the next few years? Or are you seeing a difference in the scale of decisions that customers are contemplating given the shift in the incentives for them in the last couple of years?

Yes. I mean, so first, with respect to how we think about pricing, we take all of the cost of production and freight into consideration in setting that. And that does include labor costs. I think what I would highlight, though, is that, look, we are a Great Place to Work.

And I think that part of being a Great Place to Work is paying a competitive wage to coincide with where people live and the work that they're doing. And we are moving that forward and up where we need to, to be competitive in the areas where we are. I mean there really are labor shortages and challenges in so many places that, that is an increasing cost for the business, but I believe we have that covered from a pricing standpoint.

With respect to your second question, I think that consumer -- there's so much consumer excitement and pull for sustainable solutions that brand owners are getting all over this. And that's a good thing for us with respect to working with us to help develop solutions for them that are more sustainable. So I think that's factored into our growth rate assumptions, but it could get even better as things get adopted more quickly.

So I think with our sort of projections right now around 10% growth, that's a good way to think about that, but could be even better as there's greater consumer adoption or OEM brand owner adoption.

Our next question comes from Mike Harrison with Seaport Global.

Can you hear me, okay?

Yes, Mike.

Great. Wanted to ask about the Clariant synergy number and the increase that you made there. Does that mean that you're finding additional projects? Or should we think about it more as an acceleration of the savings that you were expecting? And can you maybe also comment on whether you're seeing some revenue synergies from the Clariant business?

Yes. I mean right now, I'd say it's just an acceleration of our capture rate, if you will. I mean, starting the year, I would have said it would be maybe around 8 or 9 for the quarter. We're doing a little bit better than that as we had in our bridge schedule. And look, right now, I'd say the primary focus of our commercial teams is just taking care of our customers, right? We just brought 2 really big organizations together.

We want our customers to genuinely believe and feel like it's business as usual or if not, then better. That's number one. And then I think we can start to move forward on some of the revenue synergies, particularly to Laurence's last question around sustainable solutions, I think that's the greatest opportunity for synergies between the 2 organizations, is focusing on those sustainable solutions, particularly in the area of packaging.

All right. And then speaking of packaging, I think you kind of addressed that it's a 5% grower this quarter when other areas are double digits. And obviously, that's because you're up against more challenging comps.

With the reopening that's going and -- going on and the vaccine rollout, are we going to see that business come up against challenging comps and maybe be one of the weaker growers? And can you maybe also discuss your share position in that market and whether you've gained any share over the past few quarters?

Yes. I mean the first way I think about our packaging end market exposure is one that is very stable, right? I mean, obviously, necessary, important, a lot of demand for it and played well during the pandemic last year. That's an important way of thinking about it. The way that kind of played out last year, candidly, was a little lumpy in terms of looking at some spikes in demand at the end of March and in April of last year, maybe a little bit again in the fall in different regions.

But -- so some of that will play out in the comparisons as it already did in the first quarter. But I don't think it's going to really be anything we would view as a negative. And I, again, certainly look at our presence in that end market as a positive. We've got confidence in our projections here for the second quarter, which are very strong. And so I don't view that as a headwind of any kind.

And the share gain?

Look, I think at the moment, I think, again, as I maybe was just commenting earlier around bringing legacy Clariant, legacy PolyOne together, and this is kind of how I feel about the pandemic in general. I really think customers have just been so focused on surety of supply, ensuring that they have quality, on-time delivery, which is so difficult right now.

I can't really point to something and say there's been some immediate share gain outside of what might just be related to these supply disruptions where we've been able to step in and serve them better. But I think it's been a small number so far this year.

(Operator Instructions) Our next question comes from Jaideep Pandya with On Field Research.

Firstly, can you just explain to us like what are the main sort of areas that you serve into health care? And like as we see vaccine rollout, what are the areas that you're sort of benefiting from? Is it really vials? Are you at all linked to some of these packaging material for, critical material for vaccine? So would be very curious to know what's going on in your health care portfolio?

The second question is really just around the 5G rollout for your cables business. Is it more 2022, 2023 story for you? Or is this really going to kick in, in the second half of this year? That's my second question.

And then just thirdly, when you look at the Clariant portfolio, and you're doing a great job on the cost side of things. But when you look at the fundamental growth side of things, what are the most exciting areas for you in terms of growth opportunities as Avient now?

Yes. Sorry about that. My phone just sounded off for some reason. I had it quiet, but apparently not. So I may have you replay the second question, but I'll take the first one. And that is around health care. And I mean, look, there are probably 15 different sort of submarkets, if you will, inside of health care, when we look at those, the biggest being medical devices, drug delivery devices and packaging around those.

That can include vials and testing and test kits and related packaging There's really -- it's interesting because for us, health care is so similar to the broader business, right, where each application is pretty small. But some of our health care customers are some of our biggest customers in an array of different applications like that.

What we think we're seeing, obviously, last year, we had really strong demand for face masks. We don't think that replays to the same level this year, but it's being more than offset by, I think, more elective procedures. Certainly, some of the testing that's going on right now is doing that. But I think that's where that growth is coming from. Can you repeat the second question for me? Again, I'm sorry.

Sure. No, that's fine. It was just related to 5G and your fiber optic cable business. Have you started seeing growth already this year? Or is it more a 2022, 2023 story as 5G rolls out.

No, we are seeing growth in that. And actually, I think that when I look at growth this year, to some extent, look, wire and cable industry in general last year was impacted by shutdowns related to COVID, not necessarily anything related to demand, but just being able to operate facilities. So I think this year, with those facilities being fully operational, we're going to have good growth related to 5G and for our fiber line business.

So look, we have a really long way to go with respect to participating in that market and the growth related to it. As we sit here today and we see 5G pop up on our phone, it's really not all the way there yet because it's really still using 4G infrastructure, and there's so much investment yet to take place.

If you just think about the really thousands and perhaps millions of mini-towers and antennas that are yet to be installed, that's going to be a growth driver for us for the next 7 to 10 years easily. Historically, when I look at our participation in that market, that's been 8% to 10% sales growth this year and -- in the past, I think that will continue to be the case.

Outside of that, like when I think about these areas where I'm most excited about growth, it really comes back to the bridge schedule that we've been using to articulate how we think about 6.5% sales growth which is really by end market, of course, health care. We capture consumer. A lot of that's in the composite space. And from a technology standpoint, because composites and sustainable solutions are really at the top of the list.

Thank you. I'm not showing any further questions at this time. I would now like to turn the call back over to Bob Patterson for closing remarks.

All right. Well, thank you, and thanks to everyone who was able to join us on the call today. If we don't see you at a conference between now and then, we look forward to providing update for our second quarter results at the conclusion thereof. Thanks, everyone.

This concludes today's conference call. Thank you for participating. You may now disconnect.